Nanalysis Announces Closing of Second Tranche to Complete its $3.4 Million Offering

Executive Summary

• Nanalysis Scientific Corp. closed the second and final tranche of its $3.4 million non‑brokered private placement, raising an additional $921,795 in gross proceeds.
• The tranche consisted of 6,145,300 units issued at $0.15 per unit, bringing total units issued under the offering to 22,671,583.
• Each unit includes one common share and half a warrant exercisable at $0.20 per share for up to two years (with acceleration provisions if the TSX‑V price reaches $0.30 for ten consecutive days).

Key Details

• Units Issued – Second Tranche: 6,145,300 units @ $0.15 each → $921,795 gross proceeds.
• Total Units Issued to Date: 22,671,583 units under the overall offering.
• Unit Composition: 1 common share + ½ of a common‑share purchase warrant per unit.
• Warrant Terms: Exercise price $0.20 per share; exercisable up to two years from closing date; acceleration possible if TSX‑V price ≥ $0.30 for ten consecutive trading days (expiry moves to 30 days after notice).
• Commission Paid: $2,000 cash commission/finder’s fees paid to Leede Financial Inc. for the second tranche.
• Regulatory Conditions: Offering remains subject to final acceptance by the TSX Venture Exchange; all securities subject to a statutory hold period of four months and one day.

Notable Quotes

(No executive quotes were included in the release.)